Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 06:07 am Purchase | 13G | LEAP THERAPEUTICS INC. LPTX | BALYASNY ASSET MANAGEMENT L.P. | 3,085,104 8.060% | 3,085,104 (New Position) | View |
| 2024-10-31 6:29 pm Purchase | 13D | LEAP THERAPEUTICS INC. LPTX | BeiGene Ltd. BGNE | 1,215,306 3.170% | 1,215,306 (New Position) | View |
| 2024-04-25 8:39 pm Purchase | 13G | LEAP THERAPEUTICS INC. LPTX | Samsara BioCapital L.P. | 2,442,352 6.400% | 2,442,352 (New Position) | View |
| 2024-04-19 4:31 pm Purchase | 13G | LEAP THERAPEUTICS INC. LPTX | GILEAD SCIENCES INC. GILD | 5,319,148 13.900% | 5,319,148 (New Position) | View |
| 2024-02-14 4:40 pm Purchase | 13G | LEAP THERAPEUTICS INC. LPTX | PERCEPTIVE ADVISORS LLC | 1,068,497 4.000% | 1,068,497 (New Position) | View |
| 2023-02-14 2:30 pm Sale | 13G | LEAP THERAPEUTICS INC. LPTX | PERCEPTIVE ADVISORS LLC | 6,726,496 6.800% | -1,750,000 (-20.65%) | View |
| 2022-02-14 6:55 pm Unchanged | 13G | LEAP THERAPEUTICS INC. LPTX | PERCEPTIVE ADVISORS LLC | 8,476,496 9.600% | 0 (Unchanged) | View |
| 2022-02-14 4:05 pm Sale | 13G | LEAP THERAPEUTICS INC. LPTX | HHLR ADVISORS LTD. | 0 0.000% | -3,716,240 (Position Closed) | View |
| 2022-02-11 06:30 am Purchase | 13G | LEAP THERAPEUTICS INC. LPTX | Artal International S.C.A. | 4,000,000 4.500% | 1,000,000 (+33.33%) | View |
| 2022-02-10 4:16 pm Purchase | 13G | LEAP THERAPEUTICS INC. LPTX | ELI LILLY & Co LLY | 3,151,605 3.500% | 519,384 (+19.73%) | View |
| 2021-09-28 6:58 pm Purchase | 13D | LEAP THERAPEUTICS INC. LPTX | BeiGene Ltd. BGNE | 12,153,074 13.200% | 2,543,800 (+26.47%) | View |
| 2021-02-16 4:25 pm Purchase | 13G | LEAP THERAPEUTICS INC. LPTX | HHLR ADVISORS LTD. | 3,716,240 6.200% | 3,716,240 (New Position) | View |
| 2021-02-16 3:42 pm Purchase | 13G | LEAP THERAPEUTICS INC. LPTX | PERCEPTIVE ADVISORS LLC | 8,476,496 14.200% | 1,750,000 (+26.02%) | View |
| 2021-02-12 9:06 pm Unchanged | 13G | LEAP THERAPEUTICS INC. LPTX | Artal International S.C.A. | 3,000,000 5.000% | 0 (Unchanged) | View |
| 2021-02-08 10:27 am Sale | 13G | LEAP THERAPEUTICS INC. LPTX | FMR LLC | 606,000 1.005% | -660,800 (-52.16%) | View |
| 2020-12-28 4:31 pm Purchase | 13G | LEAP THERAPEUTICS INC. LPTX | Artal International S.C.A. | 3,000,000 5.000% | 3,000,000 (New Position) | View |
| 2020-04-20 5:25 pm Purchase | 13G | LEAP THERAPEUTICS INC. LPTX | PERCEPTIVE ADVISORS LLC | 6,726,496 18.800% | 6,726,496 (New Position) | View |
| 2020-03-23 4:43 pm Purchase | 13D | LEAP THERAPEUTICS INC. LPTX | BeiGene Ltd. BGNE | 9,609,274 23.700% | 9,609,274 (New Position) | View |
| 2020-02-07 11:24 am Purchase | 13G | LEAP THERAPEUTICS INC. LPTX | FMR LLC | 1,266,800 5.107% | 309,676 (+32.35%) | View |
| 2020-01-21 5:03 pm Sale | 13D | LEAP THERAPEUTICS INC. LPTX | Valence Helix Investments III LLC | 2,283,520 8.930% | -314,908 (-12.12%) | View |